QVA149 (indacaterol/glycopyrronium)

indacaterol/glycopyrronium · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QVA149 (indacaterol/glycopyrronium), covering 2013-01-21 to 2013-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]